|
| |
| | | 68706 | | 13.09.2023 | | AstraZeneca AG | | | | | | | 12.09.2028 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Imjudo 25 mg/1,25 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Tremelimumabum 25mg / 1.25ml) | L01FX20 | | | 02 | Imjudo 300 mg/15 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Tremelimumabum 300mg / 15ml) | L01FX20 | |
|
|
|
